Rishabh Instruments Ltd

- There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript. - The company remains net debt free with a strong balance sheet and had net cash and cash equivalents of INR1,276 million as of March 31, 2026. - They discussed plans for organic growth and capacity expansion, mainly funded through internal accruals and incremental investments (e.g., new manufacturing setups). - No concrete plans or announcements were made regarding acquisitions or fundraising but acquisitions in the U.S. market are being considered to accelerate market entry. - Overall, the company appears focused on organic growth and strategic investments without indicating immediate fundraising via debt or equity.

- Nashik expansion capex completed with 2 new manufacturing facilities nearly ready, doubling production capacity to meet rising demand. - New building under construction with one entire floor dedicated to solar inverter manufacturing; assembly lines to ramp up production. - Incremental investment planned to scale solar inverter capacity up to INR100 crores. - Expansion planned for medium voltage products (CTs, PTs, VTs), solar products, and cam switches. - Focus on developing and certifying products for high-growth markets like the U.S., with plans to increase current transformer capacity from 6,000 to 10,000 units/day. - Exploring inorganic growth opportunities including potential acquisitions in the U.S. and Europe to speed market entry and product certifications. - Organic growth remains core; reinvesting profits from business for further expansion.

- EEI business expected to grow 20%-25% top line annually, targeting around INR670 crores in FY27 from INR560 crores currently. - U.S. market sales have grown 50% YoY recently, with plan to increase from USD3 million to 40%-50% higher next year; target INR100 crores business from U.S. in 3-4 years. - Alucast segment expected to have flat or slightly lower revenues (~below INR200 crores in FY27) with focus on achieving breakeven and improving margins. - Solar inverter business targeting INR24-25 crores revenues in FY27, with capacity to scale up to INR100 crores in new plant. - Overall consolidated revenue may approach INR1,000 crores by March 2028 with EBITDA around INR150-160 crores, possibly closer to INR200 crores by then. - Other smaller divisions expected to grow faster (~30%) than main EEI business (~20%).

- EEI (Electrical & Electronics Instrumentation) business expected to grow 20-25% top line in FY27. - EBITDA margin guidance for EEI segment maintained at 20-22%, with potential fluctuations due to product mix. - Overall consolidated EBITDA growth projected around 20% but with cautious margins due to geopolitical and operational factors. - Lumel and Rishabh Instruments expected to grow at ~20% top line, while smaller entities may grow faster (~30%). - EBITDA may improve with operating leverage but conservatively guided at 20-22%. - Alucast (die casting business) expected to be flat or slightly below previous revenue with focus on cost control and profitability. - By March 2028, potential to approach INR 1,000 crore revenue and INR 200 crore EBITDA consolidated, though crossing INR 1,000 crore is not guaranteed. - Continued R&D and capacity expansions in solar and medium voltage products expected to drive growth. - EPS growth expected to follow revenue and margin expansion but specific figures not disclosed.

- The company has a concrete pipeline for new orders based on substantial efforts. - They have submitted several crores worth of offers. - Numerous customer visits and audits have been conducted. - Several orders have been cleared and negotiations are ongoing. - Currently, they are negotiating prices and other business conditions with multiple prospects. - There are at least 3 to 4 new prospective customers in the negotiation phase. - Additionally, 2 to 3 existing customers are providing new projects. - This order pipeline is based on real data and not just aspirational thinking. - The order pipeline supports the company's 2-year projection to return to better revenue and margin figures.